Table 104List of excluded studies

First authorTitleJournalPublication yearNotes
Ben Sedrine 5Interest of a prescreening questionnaire to reduce the cost of bone densitometry.Osteoporosis International, 13, 434–442.(2002)Outcomes measured (diagnosis of osteoporosis) not applicable to current study (risk assessment of fragility fracture)
Harrison 20Application of a triage approach to peripheral bone densitometry reduces the requirement for central DXA but is not cost effective.Calcified Tissue International, 79, 199–206.(2006)Risk Assessment comparisons included peripheral bone densitometry and is not applicable to current study
Ito 23Using the Osteoporosis Self- Assessment Tool for Referring Oldwer Men for Bone Densitometry: A Decision AnalysisThe American Geriatrics Society(2009)OST strategy excluded in our review, treatment based on osteoporosis risk and costs from the US.
Mueller 37Cost-effectiveness of using clincial risk factors with and without DXA for osteoporosisi screening in postmenopausal womenValue in Health 12, 1106–1117.(2009)Treatment pathway included in model. Treatment criteria not applicable to current practice in the UK.
Johansson 25A comparison of case- finding strategies in the UK for the management of hip fracturesOsteoporosis International, 23, 907–915.(2012)Study did not conduct incremental analysis and therefore not applicable for our analysis.

From: Appendix E, Full health economic report

Cover of Osteoporosis: Fragility Fracture Risk
Osteoporosis: Fragility Fracture Risk: Osteoporosis: Assessing the Risk of Fragility Fracture.
NICE Clinical Guidelines, No. 146.
National Clinical Guideline Centre (UK).
Copyright © 2012, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.